0
Skip to Content
Our Pipeline
Our Team
Contact us
Open Menu
Close Menu
Our Pipeline
Our Team
Contact us
Open Menu
Close Menu
Our Pipeline
Our Team
Contact us
Celmatix Launches Novel PCOS Drug Program
Apr 13
Written By
Colleen McMillen
Colleen McMillen
Previous
Previous
Celmatix Appoints Drug Development Expert Dr. Susan Herbert to Strategic Advisory Board
Next
Next
Celmatix and Global Collaborators Announce Findings from Largest Genetic Study to Date on Endometriosis